Angion Biomedica Corp Stock Current Asset
ANGNDelisted Stock | USD 10.00 8.94 843.40% |
Angion Biomedica Corp fundamentals help investors to digest information that contributes to Angion Biomedica's financial success or failures. It also enables traders to predict the movement of Angion Stock. The fundamental analysis module provides a way to measure Angion Biomedica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Angion Biomedica stock.
Angion |
Angion Biomedica Corp Company Current Asset Analysis
Angion Biomedica's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Angion Biomedica Current Asset | 18.1 M |
Most of Angion Biomedica's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Angion Biomedica Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Angion Biomedica Corp has a Current Asset of 18.1 M. This is 99.16% lower than that of the Healthcare sector and 98.29% lower than that of the Biotechnology industry. The current asset for all United States stocks is 99.81% higher than that of the company.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Angion Fundamentals
Return On Equity | -0.54 | |||
Return On Asset | -0.21 | |||
Operating Margin | (31.48) % | |||
Current Valuation | (26.79 M) | |||
Shares Outstanding | 30.11 M | |||
Shares Owned By Insiders | 33.02 % | |||
Shares Owned By Institutions | 16.36 % | |||
Number Of Shares Shorted | 63.65 K | |||
Price To Book | 0.49 X | |||
Price To Sales | 0.90 X | |||
Revenue | 2.3 M | |||
Gross Profit | (15.8 M) | |||
EBITDA | (20.12 M) | |||
Net Income | (38.81 M) | |||
Cash And Equivalents | 63.37 M | |||
Cash Per Share | 2.10 X | |||
Total Debt | 4.2 M | |||
Debt To Equity | 0.07 % | |||
Current Ratio | 8.47 X | |||
Book Value Per Share | 1.32 X | |||
Cash Flow From Operations | (38.39 M) | |||
Short Ratio | 0.73 X | |||
Earnings Per Share | (10.11) X | |||
Target Price | 1.5 | |||
Beta | 0.6 | |||
Market Capitalization | 30.11 M | |||
Total Asset | 52.79 M | |||
Retained Earnings | (253.94 M) | |||
Working Capital | 45.06 M | |||
Current Asset | 18.1 M | |||
Current Liabilities | 5.28 M | |||
Z Score | -2.62 | |||
Net Asset | 52.79 M |
About Angion Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Angion Biomedica Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Angion Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Angion Biomedica Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Angion Biomedica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angion Biomedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will appreciate offsetting losses from the drop in the long position's value.Moving against Angion Stock
0.81 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.73 | NVO | Novo Nordisk AS | PairCorr |
0.72 | NONOF | Novo Nordisk AS | PairCorr |
0.71 | AULT | Ault Alliance Symbol Change | PairCorr |
0.7 | CSLLY | CSL | PairCorr |
The ability to find closely correlated positions to Angion Biomedica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angion Biomedica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angion Biomedica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angion Biomedica Corp to buy it.
The correlation of Angion Biomedica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angion Biomedica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies |